^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GPC3-CAR and IL15 plus IL21

    i
    Associations
    News

    Trials

    Company:
    Baylor College of Medicine
    Drug class:
    GPC-3-targeted CAR-T immunotherapy, IL-15-targeted CAR-T immunotherapy, IL-21-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04715191)
    Phase 1
    Baylor College of Medicine
    Not yet recruiting
    Last update posted :
    05/06/2024
    Initiation :
    07/03/2024
    Primary completion :
    08/01/2026
    Completion :
    07/03/2041
    GPC3
    |
    GPC3 positive
    |
    cyclophosphamide • fludarabine IV • GLYCAR T cells • GPC3-CAR and IL15 plus IL21 • cyclophosphamide intravenous